The Increasing Prevalence Of Diabetes To Propel The Continuous Glucose Monitoring (CGM) Devices Market Growth
Continuous Glucose Monitoring (CGM) Devices Market |
Continuous Glucose
Monitoring (CGM) Devices Market, by Component (Transmitters, Receivers, Insulin Pumps,
and Sensors) and by Region (North America, Latin America, Europe, Asia Pacific,
Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022
– 2030
The global continuous glucose monitoring
(CGM) devices market is estimated to be valued at US$ 8,865.65 million in 2022
and is expected to exhibit a CAGR of 24.8% during the forecast period
(2022-2030), as highlighted in a new report published by Coherent Market
Insights.
Market Overview:
Continuous Glucose Monitoring (CGM) Devices
assists one to manage the type 1 mellitus and type 2 mellitus with lesser
fingerstick trials, a sensor in the skin measures the glucose levels in the
whole day. A transmitter sends outcome to a wearable appliances or the
smartphone. It is difficult to and it needs some time for a person to learn how
to utilize the Continuous Glucose Monitoring (CGM) Devices, however, it can
assist one more easily to regulate the well-being.
Competitive Landscape:
Key players involved in the
global Continuous
Glucose Monitoring (CGM) Devices Market are Taiwan Semiconductor
Manufacturing Company Limited, Texas Instruments Inc, Insulet Corporation, and
Nemaura Medical, Inc., NXP Semiconductors, Senseonics, Medtronic, Dexcom, Inc.,
STMicroelectronics, Abbott Laboratories, Microchip Technology Inc.,Medtrum
Technologies, Inc., Tandem Diabetes Care, Glycens, Qualcomm, GE Healthcare, and
Micron Technology Inc.
Market
Key Drivers:
The increasing prevalence of
diabetes is expected to augment the growth of global continuous glucose
monitoring (CGM) devices market. For instance, as per IDF, it is estimated that
above 700 million individuals would be suffering from diabetes.
The increasing geriatric
population is anticipated to propel the growth of global continuous glucose
monitoring (CGM) devices market. For instance, as per UN Report, around 727 million people aged 65 years
or above in 2020.
Covid-19
Impact Analysis:
The Covid-19 outbreak has
had a positive impact on the growth of global Continuous Glucose Monitoring (CGM) Devices Market. The spread of
virus has increased need for the requirement of remote monitoring of COVID-19
individuals, the CGM had shown instant demand growth in COVID-19.
Key
Takeaways:
The global
continuous glucose monitoring (CGM) devices market is anticipated to
exhibit a CAGR of 24.8 % during the forecast period owing to the increasing
prevalence of obesity as obesity also leads to diabetes. For instance, as per
WHO, above 1 billion people are obese globally out of 650 million are adults.
Among regions, North America, Europe and Asia
Pacific are expected to witness robust growth in the global Continuous Glucose
Monitoring (CGM) Devices Market due to increasing prevalence of
diabetes, rising awareness of healthcare expenditure, rising geriatric
population and increasing R&D. For instance, as per ADA, around 37.3
million people suffer diabetes.
Comments
Post a Comment